Another piece of research found that the frequency of NPC1 and NPC2 variants was higher in patients with amyloid beta (Aβ) deposition, suggesting that variants in NPC genes may play a role as risk or disease-modifying factors for AD [18]. This evidence concerns the gene NPC1 and Alzheimer disease.